Increased prevalence of insulin resistance in women with a history of recurrent pregnancy loss

被引:116
作者
Craig, LB [1 ]
Ke, RW [1 ]
Kutteh, WH [1 ]
机构
[1] Univ Tennessee, Dept Obstet & Gynecol, Div Reprod Endocrinol, Hlth Sci Ctr, Memphis, TN 38163 USA
关键词
insulin resistance; recurrent pregnancy loss; fasting insulin; miscarriage;
D O I
10.1016/S0015-0282(02)03247-8
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To determine whether insulin resistance is associated with recurrent pregnancy loss (RPL). Design: Single center, case-controlled, prospective study. Setting: University-associated reproductive endocrinology clinical practice. Patient(s): Seventy-four nonpregnant, nondiabetic women with RPL. Controls were 74 fertile, nonpregnant, nondiabetic women without RPL who had at least one live infant, and were matched by age, race, and body mass index (BMI). Intervention(s): Both groups consented to obtaining fasting insulin and glucose levels. Main Outcome Measure(s): Insulin resistance was defined as a fasting insulin level >20 muU/mL or a fasting glucose to insulin ratio of <4.5. Result(s): Among the 74 women with RPL, 20 (27.0%) demonstrated insulin resistance, whereas only 7 of 74 (9.5%) of the matched controls were insulin resistant (odds ratio 3.55; 95% confidence interval 1.40-9.01). The RPL and control groups were similar with respect to age, ethunicity, and BMI. The RPL and control groups had similar fasting glucose levels and glucose-to-insulin ratios. However, fasting insulin levels greater than or equal to20 muU/mL were statistically different between the two groups (odds ratio 3.92). Conclusion(s): Women with RPL have a significantly increased prevalence of insulin resistance when compared with matched fertile controls. (C) 2002 by American Society for Reproductive Medicine.
引用
收藏
页码:487 / 490
页数:4
相关论文
共 20 条
[1]   Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity - Studies in subjects with various degrees of glucose tolerance and insulin sensitivity [J].
Bonora, E ;
Saggiani, F ;
Targher, G ;
Zenere, MB ;
Alberiche, M ;
Monauni, T ;
Bonadonna, RC ;
Muggeo, M .
DIABETES CARE, 2000, 23 (01) :57-63
[2]   AN INFORMATIVE PROTOCOL FOR THE INVESTIGATION OF RECURRENT MISCARRIAGE - PRELIMINARY EXPERIENCE OF 500 CONSECUTIVE CASES [J].
CLIFFORD, K ;
RAI, R ;
WATSON, H ;
REGAN, L .
HUMAN REPRODUCTION, 1994, 9 (07) :1328-1332
[3]   EPIDEMIOLOGY OF RECURRENT SPONTANEOUS-ABORTION [J].
COULAM, CB .
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1991, 26 (01) :23-27
[4]  
DEFRONZO RA, 1979, AM J PHYSIOL, V237, P214
[5]   The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome [J].
Dunaif, A ;
Scott, D ;
Finegood, D ;
Quintana, B ;
Whitcomb, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (09) :3299-3306
[6]   Plasminogen activator inhibitor activity: An independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome [J].
Glueck, CJ ;
Wang, P ;
Fontaine, RN ;
Sieve-Smith, L ;
Tracy, T ;
Moore, SK .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1999, 48 (12) :1589-1595
[7]   Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study [J].
Glueck, CJ ;
Phillips, H ;
Cameron, D ;
Sieve-Smith, L ;
Wang, P .
FERTILITY AND STERILITY, 2001, 75 (01) :46-52
[8]  
GORDON MC, 1995, AM J OBSTET GYNECOL, V173, P189
[9]  
GRIS JC, 1993, J LAB CLIN MED, V122, P606
[10]  
Gris JC, 1997, THROMB HAEMOSTASIS, V77, P1096